Key result
Intravenous verapamil was evaluated for its hemodynamic effects in patients with coronary artery disease receiving propranolol, but the abstract lacks specific results.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
No actionable results to guide practice; leaves open verapamil-propranolol hemodynamic effects in CAD.
Kieval et al. (1982) studied this question. Intravenous verapamil was evaluated for its hemodynamic effects in patients with coronary artery disease receiving propranolol, but the abstract lacks specific results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: